Crossmark

Role of gut microbiota and immune cells in metabolic-associated fatty liver disease: clinical impact

Published Online: 2024-07-12

Published Print: 2024-10

Authors

Alisi, Anna https://orcid.org/0000-0001-7241-6329
McCaughan, Geoffrey

Grønbæk, Henning
Funding

Funding for this research was provided by:

Ministero della Salute (PNRR-MAD-2022-12375633)
License Information

Text and Data Mining valid from 2024-07-12

Version of Record valid from 2024-07-12
More Information

Article History

Received: 24 January 2024

Accepted: 18 March 2024

First Online: 12 July 2024

Declarations

:

: Anna Alisi declares she has no financial interests. Geoffrey McCaughan has no financial interests. Henning Grønbæk received research grants from Abbvie, Intercept, ARLA Food for Health, AIDS AIPHIA Development Services AG. Consultant and speaker’s bureau at Ipsen, NOVO Nordisk, Pfizer, AstraZeneca. Data Monitoring Committee CARAMUS.

: This article does not contain any studies with human or animal subjects.

Document is current